[{"NetIncomeLoss_1_Q2_USD":-14953000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":43960794.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":435000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.699,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":0.699,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":18000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.0106,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.0106,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-129649000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":161916000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":2113000.0,"AssetsCurrent_0_Q2_USD":354309000.0,"OperatingLeaseExpense_2_Q2_USD":1400000.0,"OperatingLeaseExpense_1_Q2_USD":700000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-71000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":206672000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":21849000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":162258000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingLeaseRightOfUseAsset_0_Q2_USD":11126000.0,"ShareBasedCompensation_2_Q2_USD":6657000.0,"Assets_0_Q2_USD":383340000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":43113195.0,"CommonStockSharesIssued_0_Q2_shares":44209968.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":466000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":1399000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":6701040.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":6701040.0,"ContractWithCustomerLiability_0_Q2_USD":11500000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":11428000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":2046000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_2_Q2_pure":0.25,"ProvisionForDoubtfulAccounts_2_Q2_USD":0.0,"OtherDeferredCostsNet_0_Q2_USD":3096000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":2909000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q2_USD":0.0,"NumberOfReportableSegments_2_Q2_Segment":1.0,"IncomeTaxExpenseBenefit_1_Q2_USD":8000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":5000.0,"AccountsReceivableNetCurrent_0_Q2_USD":9278000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":1400000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-36000.0,"LoansPayableCurrent_0_Q2_USD":2786000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":76508000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":15877000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":11687000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":21183000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1841000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-48000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":13.55,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":168859000.0,"CostsAndExpenses_1_Q2_USD":36617000.0,"OperatingLeaseLiability_0_Q2_USD":11878000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":4000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-25000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-364000.0,"Liabilities_0_Q2_USD":44593000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":547951000.0,"CostsAndExpenses_2_Q2_USD":69988000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":8518000.0,"OtherAssetsNoncurrent_0_Q2_USD":3647000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-75000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":462000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-14930000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-27361000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":342000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":70080000.0,"ShortTermInvestments_0_Q2_USD":258827000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":12.34,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":4991000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":6657000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3600000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":21000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":19000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-37674000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":4225000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":5059000.0,"CostOfRevenue_2_Q2_USD":26956000.0,"CostOfRevenue_1_Q2_USD":13502000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":3318000.0,"LiabilitiesCurrent_0_Q2_USD":34087000.0,"AccountsPayableCurrent_0_Q2_USD":8919000.0,"InterestExpense_2_Q2_USD":65000.0,"InterestExpense_1_Q2_USD":65000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":8803000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.6806,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.6939,"NetIncomeLoss_2_Q2_USD":-27357000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":14258000.0,"DividendsCommonStock_2_Q2_USD":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OperatingLeasePayments_2_Q2_USD":1400000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":1191000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-14945000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":1191000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.0062,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":70080000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.103,"AccruedIncomeTaxesCurrent_0_Q2_USD":446000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":2591000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":19000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.0094,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-27352000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":15900000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":9800000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":6219000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":383340000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":11460000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"InvestmentIncomeInterest_1_Q2_USD":103000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"InvestmentIncomeInterest_2_Q2_USD":198000.0,"OperatingIncomeLoss_1_Q2_USD":-14947000.0,"OperatingIncomeLoss_2_Q2_USD":-27437000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":21670000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":42551000.0,"CommonStockValueOutstanding_0_Q2_USD":4000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":100000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2181000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":6657000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":19000000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":18900000.0,"CommonStockSharesOutstanding_0_Q2_shares":44209968.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":2928000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":1555000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-209226000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":4544000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3600000.0,"StockholdersEquity_0_Q2_USD":338747000.0,"ProfitLoss_2_Q2_USD":-27357000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.34,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.63,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":1700000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-1390000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3360000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1988000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-9573000.0,"Ticker":"PSNL","CIK":"1527753","name":"PERSONALIS, INC.","OfficialName":"Personalis Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"307257592.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20210804"}]